Duke University Cancer Institute

Durham, North Carolina 27710

0 studies enrolling now · 3 studies all time

What they study most

Advanced Melanoma, Advanced Solid Tumor, Malignant Melanoma (Cutaneous), Melanoma, Metastatic Melanoma, Non-small Cell Lung Cancer (NSCLC), Pancreatic Adenocarcinoma, Unresectable Melanoma

Studies at this site

• CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma — Stopped early
• A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors — Running, not enrolling
• CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma — Stopped early